Newly Launched Eir Ventures To Target ‘Early Nordic Opportunities’
BY STEN STOVALL Executive Summary The Nordic region’s vibrant life sciences ecosystem will be the chief focus for newly created Eir Ventures, a strategic partnership and investment company.
Nordic investment fund Eir Ventures has just launched, armed with €76m ($85m) that mangers say will be invested in innovative life science companies in the region to advance cutting-edge therapies and technologies there that might otherwise not get the attention they deserve. The new Nordic life science venture fund was officially created this month with the support from an investor syndicate comprising Saminvest, the European Investment Fund (EIF), Vækstfonden, Novo Holdings, as well as additional private investors. “We expect to invest around two thirds of the fund’s money in the Nordic region, with the remainder going to prospects in the US and EU,” said Stephan Christgau, a managing partner at Eir Ventures. The plan is to gradually expand the fund’s investment fire power to €100m ($112m) via future closing rounds.
17 / September 2020
© Informa UK Ltd 2020 (Unauthorized photocopying prohibited.)
